X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare JUBILANT LIFE SCIENCES with Torrent Pharma - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

JUBILANT LIFE SCIENCES vs TORRENT PHARMA - Comparison Results

TORRENT PHARMA 
   Change

Torrent Pharmaceuticals Ltd. is the flagship company of the Torrent Group set up in 1959. Based in Ahmedabad, it was promoted by Mr U.N. Mehta initially as Trinity Laboratories Ltd. and was later renamed to its current name. The company derives its r... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    JUBILANT LIFE SCIENCES TORRENT PHARMA JUBILANT LIFE SCIENCES/
TORRENT PHARMA
 
P/E (TTM) x 23.9 28.6 83.6% View Chart
P/BV x 4.9 5.4 90.3% View Chart
Dividend Yield % 0.4 1.0 37.0%  

Financials

 JUBILANT LIFE SCIENCES   TORRENT PHARMA
EQUITY SHARE DATA
    JUBILANT LIFE SCIENCES
Mar-14
TORRENT PHARMA
Mar-17
JUBILANT LIFE SCIENCES/
TORRENT PHARMA
5-Yr Chart
Click to enlarge
High Rs1871,768 10.6%   
Low Rs651,186 5.5%   
Sales per share (Unadj.) Rs364.3346.1 105.3%  
Earnings per share (Unadj.) Rs6.855.2 12.4%  
Cash flow per share (Unadj.) Rs24.573.3 33.4%  
Dividends per share (Unadj.) Rs3.0014.00 21.4%  
Dividend yield (eoy) %2.40.9 251.2%  
Book value per share (Unadj.) Rs164.9257.1 64.1%  
Shares outstanding (eoy) m159.28169.22 94.1%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x0.34.3 8.1%   
Avg P/E ratio x18.426.8 68.7%  
P/CF ratio (eoy) x5.120.1 25.5%  
Price / Book Value ratio x0.85.7 13.3%  
Dividend payout %43.825.4 172.7%   
Avg Mkt Cap Rs m20,061249,887 8.0%   
No. of employees `0006.211.8 52.5%   
Total wages/salary Rs m11,0529,934 111.3%   
Avg. sales/employee Rs Th9,383.04,971.5 188.7%   
Avg. wages/employee Rs Th1,786.9843.2 211.9%   
Avg. net profit/employee Rs Th176.3792.4 22.2%   
INCOME DATA
Net Sales Rs m58,03458,569 99.1%  
Other income Rs m1912,233 8.5%   
Total revenues Rs m58,22460,802 95.8%   
Gross profit Rs m5,78613,773 42.0%  
Depreciation Rs m2,8123,069 91.6%   
Interest Rs m3,2372,056 157.5%   
Profit before tax Rs m-7210,881 -0.7%   
Minority Interest Rs m-2860-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m2,1450-   
Tax Rs m6961,545 45.1%   
Profit after tax Rs m1,0909,336 11.7%  
Gross profit margin %10.023.5 42.4%  
Effective tax rate %-965.914.2 -6,801.9%   
Net profit margin %1.915.9 11.8%  
BALANCE SHEET DATA
Current assets Rs m29,28053,841 54.4%   
Current liabilities Rs m38,91231,612 123.1%   
Net working cap to sales %-16.638.0 -43.7%  
Current ratio x0.81.7 44.2%  
Inventory Days Days8497 86.8%  
Debtors Days Days5184 60.5%  
Net fixed assets Rs m55,71242,079 132.4%   
Share capital Rs m155846 18.3%   
"Free" reserves Rs m20,96842,655 49.2%   
Net worth Rs m26,26543,501 60.4%   
Long term debt Rs m17,16922,408 76.6%   
Total assets Rs m88,606101,250 87.5%  
Interest coverage x1.06.3 15.5%   
Debt to equity ratio x0.70.5 126.9%  
Sales to assets ratio x0.70.6 113.2%   
Return on assets %4.911.3 43.4%  
Return on equity %4.221.5 19.3%  
Return on capital %11.619.6 58.9%  
Exports to sales %37.80-   
Imports to sales %16.50-   
Exports (fob) Rs m21,933NA-   
Imports (cif) Rs m9,567NA-   
Fx inflow Rs m22,00420,066 109.7%   
Fx outflow Rs m11,7495,304 221.5%   
Net fx Rs m10,25514,762 69.5%   
CASH FLOW
From Operations Rs m8,02610,127 79.3%  
From Investments Rs m-1,744-7,869 22.2%  
From Financial Activity Rs m-4,447-1,918 231.9%  
Net Cashflow Rs m1,834212 867.4%  

Share Holding

Indian Promoters % 45.6 71.5 63.8%  
Foreign collaborators % 3.5 0.0 -  
Indian inst/Mut Fund % 8.7 7.0 123.9%  
FIIs % 21.2 12.6 168.3%  
ADR/GDR % 0.0 0.0 -  
Free float % 21.1 8.8 239.8%  
Shareholders   23,815 26,511 89.8%  
Pledged promoter(s) holding % 15.9 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare JUBILANT LIFE SCIENCES With:   PANACEA BIOTECH  DISHMAN PHARMA  TTK HEALTHCARE  NATCO PHARMA  DIVIS LABORATORIES  

Compare JUBILANT LIFE SCIENCES With:   ACTAVIS (US)  MYLAN (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends Day in Red; Realty Stocks Top Losers(Closing)

After opening the day in green, share markets in India witnessed volatile trading activity throughout the day and ended the day on a dull note.

Related Views on News

Most Popular

Retail Investors or Chickens Waiting to Get Slaughtered in the Stock Market?(Vivek Kaul's Diary)

Jan 9, 2018

The price to earnings ratio of the Nifty 50 is very close to all-time high levels.

Is it Wise to Ignore Bitcoins?(The 5 Minute Wrapup)

Jan 4, 2018

While investing in bitcoins, it would make sense to treat it as another asset class and decide accordingly.

Best ELSS Funds In 2018: Don't Blindly Chase Top Performers(Outside View)

Jan 10, 2018

As the tax-saving season begins, investors hunt for the best ELSS funds for 2018. PersonalFN provides a list of the top ELSS mutual funds of the past year.

Resolutions for 2018 - by others(The Honest Truth)

Jan 8, 2018

Ten quirky new year resolutions. Guess by whom?

Bitcoin Beginners Should Do These Three Things...(Smart Contrarian)

Jan 10, 2018

Three simple points to keep in mind before you consider buying bitcoin.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

JUBILANT LIFE SCIENCES SHARE PRICE


Jan 16, 2018 (Close)

TRACK JUBILANT LIFE SCIENCES

  • Track your investment in JUBILANT LIFE SCIENCES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON JUBILANT LIFE SCIENCES

JUBILANT LIFE SCIENCES 8-QTR ANALYSIS

COMPARE JUBILANT LIFE SCIENCES WITH

MARKET STATS